IBB News and Press, iShares Biotechnology ETF From 01/24/26

2026-01-24 14:20:00 ET The biotech sector returned to health in 2025 after years of sickly returns. A key sign of vitality was the SPDR S&P Biotech ETF (NASDAQ: IBB) , which rose 27% in 2025, nearly doubling the 16% gain by the S&P 500 . Lower interest rates aided th...

2026-01-22 13:04:02 ET More on Novartis Novartis AG (NVS) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Novartis AG (NVS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Novartis: A Mispriced Hedge In A Crowded Equity Mark...

2026-01-22 06:07:00 ET By Vinay Thapar, CFA and Jane Bleeg More clarity on regulatory and policy issues can help healthcare stocks reassert their fundamental strengths. Read the full article on Seeking Alpha For further details see: Are Healthcare Stocks Pois...

2026-01-13 06:30:00 ET Transcript We just had three years of double-digit returns for S&P 500 that is quite rare, and if we make it into four depends a lot on earnings. Q4 is starting to report, and there are three themes on my mind.... Read the full article on...

2026-01-08 13:15:11 ET More on biotech, biopharma Biotech: Time For A Pause To Start 2026 2026 Market Outlook: S&P 500 Looks Expensive, But Biotech Could Outperform Under The Hood iShares Biotechnology ETF: The M&A Wave Behind The Suddenly Booming Biotech Sec...

2026-01-08 05:30:00 ET After a prolonged slump, investors are giving the healthcare sector a second look as lower interest rates, potential M&A and even AI innovation help to improve the outlook. Jacky He, Vice President for Portfolio Research at TD Asset Management, joins MoneyTalk...

2025-12-30 08:57:41 ET Since my October article , Biogen Inc. ( BIIB ) stock has risen 18.4%, outperforming the S&P 500 [2.9% return] ( SPY ), as well as two "bellwethers" for the biotech investors, the iShares Biotechnology ETF [14%] ( IBB ) and VanEck Biotech ETF [...

2025-12-19 03:10:00 ET By Frank Coughlin A clear story has emerged from the third quarter earnings season - one of divergence. We are seeing a market split between companies benefiting from major secular growth trends and those navigating more traditional economic cycles.... ...

2025-12-16 08:14:04 ET More on iShares Biotechnology ETF iShares Biotechnology ETF: The M&A Wave Behind The Suddenly Booming Biotech Sector IBB: Biotech's Leading Players, All In One ETF Short bets on S&P 500 Healthcare sector rises to 2.12% in November; MRNA...

2025-12-12 09:35:30 ET More on The Health Care Select Sector SPDR® Fund ETF XLV: The Simple Case For Overweighting U.S. Health Care Healthcare ETFs: I Prefer VHT's Growth To XLV's Stability XLV: Lower Interest Rates And A Positive Growth Outlook Will Pave The Wa...